Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need ...

Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward ...

Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...

In our cover story this month, Danny Buckland looks at weight loss medication and how GLP-1s have been shown to provide game-changing opportunities for patients who are overweight or obese to improve ...

Icotyde (icotrokinra) has been approved by the US FDA to treat moderate-to-severe plaque psoriasis (PsO) in both adults and ...

Envision Pharma Group (Envision) has appointed Darren Coleman as Executive Vice President, Chief Information Officer. Coleman ...

AL-S Pharma has released new data from the phase 2 trial evaluating its drug AP-101 in patients with amyotrophic lateral ...

Envision Pharma Group (Envision) has appointed Jay Ferro as President, Technology and Chief Product Officer (CPO). He joins ...

At the end of last year, we wrote a piece on artificial intelligence (AI) persona generation and the conceptual hurdle teams ...